Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Takeuchi, Masayoshi ^a   Takino, Jun Ichi ^b   Furuno, Satomi ^c   Shirai, Hikari ^c   Kawakami, Mihoko ^c   Muramatsu, Michiru ^c   Kobayashi, Yuka ^c   Yamagishi, Sho Ichi ^d  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FRUCTOSE DERIVED ADVANCED GLYCATION END PRODUCT; GLUCOSE DERIVED ADVANCED GLYCATION END PRODUCT; GLYCERALDEHYDE DERIVED ADVANCED GLYCATION END PRODUCT; N EPSILON (CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG; ANTIBODY; BIOLOGICAL MARKER; LYSINE; N(6)-CARBOXYMETHYLLYSINE;

ARTICLE; BEVERAGE; CARBONATED BEVERAGE; CEREAL; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD ANALYSIS; FOOD PROCESSING; FRUIT JUICE; JAPAN; SPORTS DRINK; ANALOGS AND DERIVATIVES; ANALYSIS; ATHEROSCLEROSIS; BLOOD; HUMAN; IMMUNOLOGY; METABOLISM; RISK FACTOR;

RATTUS;

ANTIBODIES; ATHEROSCLEROSIS; BEVERAGES; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOD ANALYSIS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; JAPAN; LYSINE; RISK FACTORS;

EID: 84923884900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118652     Document Type: Article

References (38)

1. Monnier VM, Cerami A. Non-enzymatic browning in vivo: possible process for aging of long-lived proteins. Science. 1981; 211: 491-493. PMID: 6779377
2. Bucala R, Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol. 1992; 23: 1-34. PMID: 1540533
3. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest. 1994; 70: 138-151. PMID: 8139257
4. Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med. 1995; 46: 223-234. PMID: 7598459
5. Takeuchi M, Makita Z. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo. Curr Mol Med. 2001; 1: 305-315. PMID: 11899079
6. Goldberg T, Cai W, Peppa M, Dardaine V, Baliga BS, Uribarri J, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 2004; 104: 1287-1291. PMID: 15281050
7. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010 110: 911-916. doi: 10.1016/j.jada.2010.03.018 PMID: 20497781
8. Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bugel S, Nielsen J, et al. Advanced glycation end products in food and their effects on health. Food Chem Toxicol. 2013; 60: 10-37. doi: 10.1016/j.fct.2013.06.052 PMID: 23867544
9. Sebekova K, Somoza V. Dietary advanced glycation endproducts (AGEs) and their health effects-PRO. Mol Nutr Food Res. 2007; 51: 1079-1084. PMID: 17854003
10. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response oxidative stress, and aging. J Gerontol A Biol Sci Med Sci. 2007; 62: 427-433. PMID: 17452738
11. Semba RD, Ang A, Talegawkar S, Crasto C, Dalal M, Jardack P, et al. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study. Eur J Clin Nutr. 2012; 66: 3-9. doi: 10.1038/ejcn.2011.139 PMID: 21792213
12. Alamir I, Niquet-Leridon C, Jacolot P, Rodriguez C, Orosco M, Anton PM, et al. Digestibility of extruded proteins and metabolic transit of N-ε-carboxymethyllysine in rats. Amino Acids. 2013; 44: 1441-1449. doi: 10.1007/s00726-012-1427-3 PMID: 23160731
13. Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T. Detection of non-carboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Mol Med. 1999; 5: 393-405. PMID: 10415164
14. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med. 2000; 6: 114-125. PMID: 10859028
15. Takeuchi M, Yanase Y, Matsuura N, Yamagishi S, Kameda Y, Bucala R, et al. Immunological detection of a novel advanced glycation end-product. Mol Med. 2001; 7: 783-791. PMID: 11788793
16. Takeuchi M, Iwaki M, Takino J, Shirai H, Kawakami M, Bucala R, et al. Immunological detection of fruc-tose-derived advanced glycation end-products. Lab Invest. 2010; 90: 1117-1127. doi: 10.1038/labinvest.2010.62 PMID: 20212455
17. Takeuchi M, Yamagishi S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Med Hypotheses. 2004; 63: 449-452. PMID: 15288366
18. Takeuchi M, Yamagishi S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J Alzheimers Dis. 2009; 16: 845-858. doi: 10.3233/JAD-2009-0974 PMID: 19387117
19. Takeuchi M, Takino J, Yamagishi S. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: A novel therapeutic strategy. Curr Drug Targets. 2010; 11: 1468-1482. PMID: 20583971
20. Sato T, Wu X, Shimogaito N, Takino J, Yamagishi S, Takeuchi M. Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys. Eur J Nutr. 2009; 48: 6 -11. doi: 10.1007/s00394-008-0753-4 PMID: 19083041
21. Tsunosue M, Makiko N, Ohta Y, Matsuo Y, Ueda K, Ninomiya M, et al. An α-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes. Clin Exp Med. 2010; 10: 139-141. doi: 10.1007/s10238-009-0074-9 PMID: 19834782
22. Tahara N, Yamagishi S, Matsui T, Takeuchi M, Nitta Y, Kodama N, et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in non-diabetic subjects. Cardiovasc Ther. 2012; 30: 42-48. doi: 10.1111/j.1755-5922.2010.00177.x PMID: 20626403
23. Tahara N, Yamagishi S, Takeuchi M, Honda A, Tahara A, Nitta Y, et al. Positive association between serum level of glyceraldehyde-derived advanced glycation end products (AGEs) and vascular inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Diabetes Care. 2012; 35: 2618-2625. doi: 10.2337/dc12-0087 PMID: 22912424
24. Ueda S, Yamagishi S, Matsui T, Noda Y, Ueda SI, Jinnouchi Y, et al. Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects. Cardiovasc Ther. 2012; 30: 249-254. doi: 10.1111/j.1755-5922.2011.00264.x PMID: 21884000
25. Fukushima Y, Daida H, Morimoto T, Kasai T, Miyauchi K, Yamagishi SI, et al. Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: The JAPAN-ACS Sub-study. Cardiovasc Diabetol. 2013; 12: 5. Available: http://www.cardiab.com/content/12/1/5. doi: 10.1186/1475-2840-12-5 PMID: 23289728
26. Ueda S, Yamagishi S, Takeuchi M, Kohno K, Shibata R, Matsumoto Y, et al. Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure. Mol Med. 2006; 12: 180-184. PMID: 17088950
27. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem. 2002; 277: 20309-20315. PMID: 11912219
28. Vlassara H, Striker GE. AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol. 2011; 7: 526-539. doi: 10.1038/nrendo.2011.74 PMID: 21610689
29. Semba RD, Gebauer SK, Baer DJ, Sun K, Turner R, Silber HA, et al. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial. J Nutr. 2014; 44: 1037-1042.
30. Kellow NJ, Savige GS. Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur J Clin Nutr. 2013; 67: 239-248. doi: 10.1038/ejcn.2012.220 PMID: 23361161
31. Henle T. Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids. 2005; 29: 313-322. PMID: 15997413
32. Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res. 2009; 8: 754-769. doi: 10.1021/pr800858h PMID: 19093874
33. ε-(carboxymethyl)lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids. 2009; 36: 317-326. doi: 10.1007/s00726-008-0071-4 PMID: 18389168
34. Schalkwijk CG, Stehouwer CD, van Hinsbergh VW. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metab Res Rev. 2004; 20: 369-382. PMID: 15343583
35. Ahmed N, Argirov OK, Minhas HS, Cordeiro CA, Thornalley PJ. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-Nhydroxysuccinimidylcarbamate and application to N-epsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. Biochem J. 2002; 364: 1-14. PMID: 11988070
36. Ahmed N, Mirshekar-Syahkal B, Kennish L, Karachalias N, Babaei-Jadidi R, Thornally PJ. Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol Nutr Food Res. 2005; 49: 691-699. PMID: 15945118
37. Koschinsky T, He CL, Mitsuhashi T, Bucala R, Liu C, Buenting C, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA. 1997; 94: 6474-6479. PMID: 9177242
38. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem. 1992; 267: 5133-5138. PMID: 1371995